Geethani Bandara

Title: Geethani Bandara: Innovator in Gene Therapy

Introduction

Geethani Bandara is a prominent inventor based in Milburn, NJ (US). She has made significant contributions to the field of gene therapy, particularly in the treatment of connective tissue disorders. Her innovative work focuses on developing methods to inhibit leukocyte infiltration and cartilage degradation in joints.

Latest Patents

Geethani Bandara holds a patent for "Viral vectors to inhibit leukocyte infiltration or cartilage degradation of joints." This invention involves a method of introducing at least one gene encoding a product into the connective tissue cells of a mammalian host. The approach utilizes recombinant techniques to produce a DNA vector molecule containing the gene, which is then used to infect the connective cells. Additionally, the patent describes non-viral methods for gene introduction and the creation of an animal model for studying connective tissue pathology.

Career Highlights

Geethani Bandara is affiliated with the University of Pittsburgh, where she continues her research and development in gene therapy. Her work has the potential to transform treatment options for patients suffering from joint-related issues.

Collaborations

Throughout her career, Geethani has collaborated with notable colleagues, including Joseph C. Glorioso and Christopher H. Evans. These partnerships have enhanced her research and contributed to the advancement of her innovative projects.

Conclusion

Geethani Bandara is a trailblazer in the field of gene therapy, with a focus on improving treatments for connective tissue disorders. Her groundbreaking patent and collaborations highlight her commitment to advancing medical science.